Investors

Notice of Results

13 May 2015

Analyst Briefing

OptiBiotix Health Plc (AIM: OPTI), a Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes, will announce its results for the year ended 30 November 2014 on Friday 29 May 2015.

A briefing for analysts will take place at Walbrook PR, 4 Lombard Street, London EC3V 9HD at 9.30am on Friday 29 May 2015.

If you would like to register to attend the briefing, or require further information, please contact Walbrook PR on 020 7933 8780 or email optibiotix@walbrookpr.com.

 

For further information, please contact:

OptiBiotix Health Plc Stephen O'Hara, Chief Executive	www.optibiotix.com Contact via Walbrook below
Cairn Financial Advisers LLP Liam Murray / Avi Robinson	Tel: 020 7148 7900
Hybridan LLP Claire Louise Noyce	Tel: 020 3713 4581
Peterhouse Corporate Finance Ltd Lucy Williams / Duncan Vasey	Tel: 020 7469 0936
Walbrook PR Ltd Anna Dunphy Mike Wort	Tel: 020 7933 8780 or optibiotix@walbrookpr.com Mob: 07876 741 001 Mob: 07900 608 002